112 results
S-8
EX-99.1
CHRS
Coherus BioSciences, Inc.
8 Aug 24
Registration of securities for employees
4:47pm
election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or
(c) The consummation … or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s
8-K
EX-99.2
CHRS
Coherus BioSciences, Inc.
27 Jun 24
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction
8:52am
a majority of the voting power of the combined company, Coherus controls a majority of the governing body of the combined company and Coherus’ senior
8-K
CHRS
Coherus BioSciences, Inc.
4 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
on April 15, 2024.
Proposal 1. The Company’s stockholders elected by a majority of votes cast each of the Class I director nominees below, Lee N
8-K/A
EX-10.1
id4bzca2itsl1dsi
21 May 24
Financial Statements and Exhibits
5:14pm
8-K
EX-99.2
hniaaguyb00z a25kx
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K/A
EX-99.2
zasd993xszacwwh8t1ys
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.1
7202se5
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
5qrjv2sxj ids
12 Sep 23
Prospectus supplement for primary offering
6:04am
424B3
mu34qd 3wpf6
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
hkxou ducwr
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
ra5pgi3w85czjkzzs5yw
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
jji16gsruk ms3ez6uky
16 Jun 23
Business combination disclosure
5:12pm
425
4ga3px6b
16 Jun 23
Business combination disclosure
5:11pm